[1]
|
Chen, P., Huang, Z., Chen, L., Zhuang, S., Lin, H., Xie, J., et al. (2021) The Relationships between Lncrna NNT-AS1, CRP, PCT and Their Interactions and the Refractory Mycoplasma pneumoniae Pneumonia in Children. Scientific Reports, 11, Article No. 2059. https://doi.org/10.1038/s41598-021-81853-w
|
[2]
|
Song, Z., Jia, G., Luo, G., Han, C., Zhang, B. and Wang, X. (2023) Global Research Trends of Mycoplasma Pneumoniae Pneumonia in Children: A Bibliometric Analysis. Frontiers in Pediatrics, 11, Article 1306234. https://doi.org/10.3389/fped.2023.1306234
|
[3]
|
Li, Y., Guo, Z., Zhang, G., Tian, X., Li, Q., Chen, D., et al. (2020) The Correlation between Vitamin a Status and Refractory Mycoplasma Pneumoniae Pneumonia (RMPP) Incidence in Children. BMC Pediatrics, 20, Article No. 359. https://doi.org/10.1186/s12887-020-02254-y
|
[4]
|
Subspecialty Group of Respiratory Diseases, The Society of Pediatrics, Chinese Medical Association The Editorial Board and Chinese Journal of Pediatrics (2013) [Guidelines for Management of Community Acquired Pneumonia in Children (The Revised Edition of 2013) (II)]. Chinese Journal of Pediatrics, 51, 856-862.
|
[5]
|
Tamura, A., Matsubara, K., Tanaka, T., Nigami, H., Yura, K. and Fukaya, T. (2008) Methylprednisolone Pulse Therapy for Refractory Mycoplasma Pneumoniae Pneumonia in Children. Journal of Infection, 57, 223-228. https://doi.org/10.1016/j.jinf.2008.06.012
|
[6]
|
刘田田, 王金菊, 梁艳龙, 张丽娉, 解童玲, 孙广荣. 重症难治性支原体肺炎混合感染病儿的临床特点[J]. 青岛大学学报(医学版), 2024, 60(2): 1-4.
|
[7]
|
崔小健, 张嘉懿, 郭文伟, 司萍, 沈永明, 郭伟, 张同强. 儿童难治性肺炎支原体肺炎发生塑型性支气管炎的临床特征及高危因素预测[J]. 重庆医学, 1-9.
|
[8]
|
严永东. RMPP患儿免疫功能变化及匹多莫德的治疗作用[J]. 临床儿科杂志, 2008, 26(7): 570-572
|
[9]
|
鲍汝英, 徐国成. 儿童难治性肺炎支原体肺炎的发病机制及治疗进展[J]. 齐齐哈尔医学院学报, 2022, 43(13): 1274-1278.
|
[10]
|
吴琼, 李艳华, 廖震, 等. 儿童难治性支原体肺炎感染病原菌特点和耐药性分析及血清白细胞介素18、33变化研究[J]. 中国基层医药, 2019, 26(21): 2607-2611.
|
[11]
|
Wang, N., Xu, X., Xiao, L. and Liu, Y. (2023) Novel Mechanisms of Macrolide Resistance Revealed by in Vitro Selection and Genome Analysis in Mycoplasma Pneumoniae. Frontiers in Cellular and Infection Microbiology, 13, Article 1186017. https://doi.org/10.3389/fcimb.2023.1186017
|
[12]
|
王亨, 赵顺英. 儿童难治性肺炎支原体肺炎的发病机制和诊治研究进展[J]. 世界临床药物, 2020, 41(5): 389-398.
|
[13]
|
赵梦楠, 刘宗昂, 王舰. 肺炎支原体P1蛋白的研究进展[J]. 微生物学杂志, 2011, 31(6): 84-87.
|
[14]
|
郭靖, 闫平, 殷占茹. 难治性支原体肺炎患儿血清抗炎与致炎因子表达的变化研究[J]. 中华医院感染学杂志, 2018, 28(21): 3338-3340.
|
[15]
|
陶冶, 李乐, 余资笔. 难治性肺炎支原体肺炎生物标志物研究进展[J]. 实用临床医学, 2023, 24(2): 129-134, 138.
|
[16]
|
Nilsson, A.C., Björkman, P., Welinder-Olsson, C., Widell, A. and Persson, K. (2010) Clinical Severity of Mycoplasma Pneumoniae(mp) Infection Is Associated with Bacterial Load in Oropharyngeal Secretions but Not with MP Genotype. BMC Infectious Diseases, 10, Article No. 39. https://doi.org/10.1186/1471-2334-10-39
|
[17]
|
范玉洁, 俞怡雪, 李玉琴, 张丹丹, 周卫芳. 儿童肺炎支原体肺炎中MP载量的临床意义及可能发病机制[J]. 临床肺科杂志, 2021, 26(8): 1203-1207.
|
[18]
|
王颖, 刘道路, 张瑜. 儿童难治性支原体肺炎风险因素评估[J]. 中国国境卫生检疫杂志, 2023, 46(6): 563-566.
|
[19]
|
陆明琰, 刘晓风, 张裕祥, 谢海燕, 王晓丽. 血清APOC1、LDH及炎性感染指标在难治性支原体肺炎患儿中的表达水平及其与肺通气功能、预后效果的相关性分析[J]. 现代生物医学进展, 2023, 23(18): 3519-3523.
|
[20]
|
Graw-Panzer, K.D., Verma, S., Rao, s., Miller, S.T. and Lee, H. (2009) Venous Thrombosis and Pulmonary Embolism in a Child with Pneumonia Due to Mycoplasma Pneumoniae. Journal of the National Medical Association, 101, 956-958. https://doi.org/10.1016/s0027-9684(15)31045-2
|
[21]
|
张晶, 刘奉琴, 郭春艳, 梁燕, 陈星. 儿童难治性肺炎支原体肺炎合并肺栓塞2例报告[J]. 中国实用儿科杂志, 2019, 34(12): 1043-1045.
|
[22]
|
Wang, X., Zhong, L., Chen, Z., Zhou, Y., Ye, B. and Zhang, Y. (2018) Necrotizing Pneumonia Caused by Refractory Mycoplasma Pneumonia Pneumonia in Children. World Journal of Pediatrics, 14, 344-349. https://doi.org/10.1007/s12519-018-0162-6
|
[23]
|
Chiu, C., Chiang, L. and Chen, T. (2006) Mycoplasma Pneumoniae Infection Complicated by Necrotizing Pneumonitis with Massive Pleural Effusion. European Journal of Pediatrics, 165, 275-277. https://doi.org/10.1007/s00431-005-0058-z
|
[24]
|
赵顺英, 钱素云, 陈志敏, 高恒妙, 刘瀚旻, 张海邻, 刘金荣. 儿童肺炎支原体肺炎诊疗指南(2023年版) [J]. 传染病信息, 2023, 36(4): 291-297.
|
[25]
|
岳甜甜, 黄依莲, 张珂. 难治性肺炎支原体肺炎患儿的CT影像学表现与临床特征的关系[J]. 河南医学研究, 2023, 32(19): 3594-3598.
|
[26]
|
Lee, H., Yun, K.W., Lee, H.J. and Choi, E.H. (2017) Antimicrobial Therapy of Macrolide-Resistant Mycoplasma pneumoniae Pneumonia in Children. Expert Review of Anti-infective Therapy, 16, 23-34. https://doi.org/10.1080/14787210.2018.1414599
|
[27]
|
苏然, 刘佳慧. 多西环素联合甲泼尼龙对难治性支原体肺炎患儿症状改善和肺功能的影响[J]. 当代临床医刊, 2023, 36(6): 26-28.
|
[28]
|
Lee, H., Choi, Y.Y., Sohn, Y.J., Kim, Y.K., Han, M.S., Yun, K.W., et al. (2021) Clinical Efficacy of Doxycycline for Treatment of Macrolide-Resistant Mycoplasma pneumoniae Pneumonia in Children. Antibiotics, 10, Article 192. https://doi.org/10.3390/antibiotics10020192
|
[29]
|
Cao, B., Qu, J., Yin, Y. and Eldere, J.V. (2015) Overview of Antimicrobial Options for Mycoplasma pneumoniae Pneumonia: Focus on Macrolide Resistance. The Clinical Respiratory Journal, 11, 419-429. https://doi.org/10.1111/crj.12379
|
[30]
|
刘畅, 杨晓琳, 潘凤琪, 隋登宇, 岳晓红. 不同剂量糖皮质激素治疗小儿难治性肺炎支原体肺炎合并肺外并发症的效果[J]. 航空航天医学杂志, 2020, 31(1): 36-38.
|
[31]
|
刘晓萌, 张燕北, 于海明, 等. 甲泼尼龙琥珀酸钠治疗儿童重症支原体肺炎的效果及对炎症因子的影响[J]. 中国医药导报, 2021, 18(29): 98-101
|
[32]
|
赵春兰, 赵梅, 王运芬, 等. 儿童难治性肺炎支原体肺炎的危险因素及甲泼尼龙治疗的最佳剂量探讨 [J]. 现代生物 医学进展, 2022, 22(11): 2181-2185.
|
[33]
|
雷东红, 迟建秀, 葛雯雯. 不同剂量甲泼尼龙对小儿重症 支原体肺炎的疗效及安全性观察 [J]. 临床肺科杂志, 2019, 24(7): 1210-1214.
|
[34]
|
肖永伟. 不同剂量甲泼尼龙佐治儿童难治性肺炎支原体肺炎临床疗效观察[J]. 中国医药指南, 2024, 22(3): 68-70.
|
[35]
|
李富, 雷国峰, 赵宇欣, 马惠, 张永强. 不同剂量甲泼尼龙治疗儿童难治性肺炎支原体肺炎的临床研究[J]. 西南医科大学学报, 2023, 46(6): 513-516, 529.
|
[36]
|
Yang, E., Kang, H., Rhim, J., Kang, J. and Lee, K. (2019) Early Corticosteroid Therapy for Mycoplasma pneumoniae Pneumonia Irrespective of Used Antibiotics in Children. Journal of Clinical Medicine, 8, Article 726. https://doi.org/10.3390/jcm8050726
|
[37]
|
马明铭, 李芳, 杨慧, 阿选德. 丙种球蛋白联合加倍剂量甲泼尼龙治疗常规剂量甲泼尼龙无效难治性支原体肺炎疗效观察[J]. 陕西医学杂志, 2019, 48(10): 1374-1377.
|
[38]
|
金建国, 华晴, 葛瑜. 丙种球蛋白联合阿奇霉素治疗小儿重症支原体肺炎的临床疗效及其对免疫功能的影响[J]. 临床合理用药杂志, 2022, 15(36): 38-41.
|
[39]
|
余先胜. 丙种球蛋白联合阿奇霉素治疗小儿难治性支原体肺炎的临床效果[J]. 临床合理用药杂志, 2022, 15(4): 95-97.
|
[40]
|
Shan, L., Liu, X., Kang, X., Wang, F., Han, X. and Shang, Y. (2017) Effects of Methylprednisolone or Immunoglobulin When Added to Standard Treatment with Intravenous Azithromycin for Refractory Mycoplasma pneumoniae Pneumonia in Children. World Journal of Pediatrics, 13, 321-327. https://doi.org/10.1007/s12519-017-0014-9
|
[41]
|
Monagle, P., Cuello, C.A., Augustine, C., Bonduel, M., Brandão, L.R., Capman, T., et al. (2018) American Society of Hematology 2018 Guidelines for Management of Venous Thromboembolism: Treatment of Pediatric Venous Thromboembolism. Blood Advances, 2, 3292-3316. https://doi.org/10.1182/bloodadvances.2018024786
|
[42]
|
宋绍秀, 徐勇胜. 儿童肺炎支原体肺炎合并肺栓塞9例临床分析并文献复习[J]. 山东大学学报(医学版), 2023, 61(11): 96-103.
|
[43]
|
高枫. 纤支镜支气管灌洗对儿童难治性肺炎支原体肺炎临床症状、炎症因子水平的影响[J]. 系统医学, 2022, 7(9): 10-14.
|
[44]
|
蔡卓波. 支气管镜肺泡灌洗术治疗儿童支原体肺炎合并肺实变的效果[J]. 大医生, 2023, 8(19): 29-32.
|
[45]
|
黄蓉, 刘玉玲. 不同支气管镜支气管肺泡灌洗时机治疗难治性肺炎支原体肺炎患儿的临床效果[J]. 内科, 2022, 17(5): 514-518.
|
[46]
|
邸翔, 葛宾. 治疗时机对RMPP患儿纤维支气管镜支气管肺泡灌洗术治疗效果及预后的影响[J]. 湖南师范大学学报(医学版), 2021, 18(5): 44-48.
|
[47]
|
王小严. 血浆D-二聚体水平与儿童肺炎支原体肺炎严重程度及预后的相关性研究[J]. 中国实用医药, 2023, 18(23): 49-51.
|